Relationship Between Uncontrolled Risk Factors and C-Reactive Protein Levels in Patients Receiving Standard or Intensive Statin Therapy for Acute Coronary Syndromes in the PROVE IT-TIMI 22 Trial
- 18 October 2005
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (8), 1417-1424
- https://doi.org/10.1016/j.jacc.2005.08.024
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of Intensive Glycemic Control on Levels of Markers of Inflammation in Type 1 Diabetes Mellitus in the Diabetes Control and Complications TrialCirculation, 2005
- Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/lJournal of the American College of Cardiology, 2005
- Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic SyndromeJAMA, 2004
- Early Intervention With Atorvastatin Modulates Th1/Th2 Imbalance in Patients With Acute Coronary Syndrome: From Bedside to BenchCirculation, 2004
- Fluvastatin inhibits raft dependent Fcγ receptor signalling in human monocytesAtherosclerosis, 2004
- Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary HypercholesterolemiaCirculation, 2003
- C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular EventsCirculation, 2003
- Associations Between Cardiorespiratory Fitness and C-Reactive Protein in MenArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Effect of Ciprofibrate on C-Reactive Protein and Fibrinogen LevelsAngiology, 2002
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997